Terray Therapeutics
Terray Therapeutics is a Los Angeles-based biotechnology company that combines ultra-high throughput experimentation, generative AI, biology, medicinal chemistry, automation, and nanotechnology to explore molecules and their targets for the purpose of discovering and developing small molecule therapeutics.
2
Funding Rounds
$180.0m
Money raised
Overview
Terray Therapeutics is a Los Angeles-based biotechnology company that combines ultra-high throughput experimentation, generative AI, biology, medicinal chemistry, automation, and nanotechnology to explore molecules and their targets for the purpose of discovering and developing small molecule therapeutics.
Funding
Funding series
Funding Series Analysis
The company Terray Therapeutics has raised a total of $180m in funding over 2 rounds.
Key Insights:
- Terray Therapeutics October 2024 Series B Funding Round: $120m
- Terray Series A round, February 2022: $60m
Terray Therapeutics October 2024 Series B Funding Round
$120m
Terray Series A round, February 2022
$60m
Industries
Terray Therapeutics is active in the following industries: